Method of inhibiting fibrosis with a somatostatin agonist
US7238666B2 · kind B2 · utility
0Cited by
7References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 2004 |
| Grant date | Jul 3, 2007 |
| Priority date | — |
| Expiry date | Dec 6, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of inhibiting fibrosis in a patient. The method comprises administering a therapeutically effective amount of a somatostatin, a somatostatin agonist or apharmaceutically acceptable salt thereof to said patent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.